SUVOREXANT (suvorexant) by Hetero is orexin receptor antagonists [moa]. Approved for orexin receptor antagonist [epc].
Drug data last refreshed 1mo ago
Orexin Receptor Antagonists
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Suvorexant for Treatment of AUD and PTSD
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant
Efficacy of Suvorexant on Post-operative Sleep Disturbance
Worked on SUVOREXANT at Hetero? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.